title: Pyoderma gangrenosum and tumor necrosis factor α agents.
authors.affiliation: 11 Pafsaniou St, Athens, Greece 11635. efrall@otenet.gr.
authors.forename: Efstathios
authors.initials: E
authors.lastname: Rallis
authors.forename: Elma
authors.initials: E
authors.lastname: Koumantaki-Mathioudaki
authors.forename: Amalia
authors.initials: A
authors.lastname: Tsiatoura
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Stavropoulos
authors.forename: Andreas
authors.initials: A
authors.lastname: Katsambas
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy; D003879:Dermatologic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000494:pharmacology / Q000627:therapeutic use; D000069285:Infliximab; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068800:Etanercept; D008727:Methotrexate